{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T01:28:27Z","timestamp":1789522107710,"version":"build-2803163510"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T00:00:00Z","timestamp":1770940800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T00:00:00Z","timestamp":1773964800000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100005046","name":"Natural Science Foundation of Heilongjiang Province","doi-asserted-by":"publisher","award":["PL2024H160"],"award-info":[{"award-number":["PL2024H160"]}],"id":[{"id":"10.13039\/501100005046","id-type":"DOI","asserted-by":"publisher"}]},{"name":"XinRui Cancer Support Treatment Project of China Primary Health Care Foundation","award":["cphcf-2022-226"],"award-info":[{"award-number":["cphcf-2022-226"]}]},{"name":"Haiyan Foundation of Harbin Medical University Cancer Hospital","award":["JJMS2021-28"],"award-info":[{"award-number":["JJMS2021-28"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-07799-7","type":"journal-article","created":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T09:35:33Z","timestamp":1770975333000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["m6A methylation-modified ETV1 drives multiple myeloma progression and M2 polarization of tumor-associated macrophage through transcriptional activation of RBMS1"],"prefix":"10.1186","volume":"24","author":[{"given":"Yan","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueqi","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boyang","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aijia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerou","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinling","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-0470-2437","authenticated-orcid":false,"given":"Li","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,13]]},"reference":[{"key":"7799_CR1","first-page":"58","volume":"19","author":"J Firth","year":"2019","unstructured":"Medical Masterclass c, Firth J. Haematology: multiple myeloma. Clin Med (Lond). 2019;19:58\u201360.","journal-title":"Clin Med (Lond)"},{"key":"7799_CR2","doi-asserted-by":"publisher","first-page":"375","DOI":"10.5694\/mja2.50129","volume":"210","author":"DE Joshua","year":"2019","unstructured":"Joshua DE, Bryant C, Dix C, Gibson J, Ho J. Biology and therapy of multiple myeloma. Med J Aust. 2019;210:375\u201380.","journal-title":"Med J Aust"},{"key":"7799_CR3","doi-asserted-by":"publisher","first-page":"3071","DOI":"10.1002\/ijc.33528","volume":"148","author":"P Xiang","year":"2021","unstructured":"Xiang P, Yeung YT, Wang J, Wu Q, Du R, Huang C, Jia X, Gao Y, Zhi Y, Guo F, et al. miR-17-3p promotes the proliferation of multiple myeloma cells by downregulating P21 expression through LMLN Inhibition. Int J Cancer. 2021;148:3071\u201385.","journal-title":"Int J Cancer"},{"key":"7799_CR4","doi-asserted-by":"publisher","first-page":"2731","DOI":"10.1182\/blood.2020006540","volume":"136","author":"K Nakamura","year":"2020","unstructured":"Nakamura K, Smyth MJ, Martinet L. Cancer immunoediting and immune dysregulation in multiple myeloma. Blood. 2020;136:2731\u201340.","journal-title":"Blood"},{"key":"7799_CR5","doi-asserted-by":"publisher","first-page":"101189","DOI":"10.1016\/j.neo.2025.101189","volume":"66","author":"M Kamal","year":"2025","unstructured":"Kamal M, Shishido SN, Mason J, Patel K, Manasanch EE, Orlowski RZ, Kuhn P. Single-cell proteomic analysis reveals multiple myeloma heterogeneity and the dynamics of the tumor immune microenvironment in precursor and advanced States. Neoplasia. 2025;66:101189.","journal-title":"Neoplasia"},{"key":"7799_CR6","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.1038\/s41375-024-02391-8","volume":"38","author":"J Sun","year":"2024","unstructured":"Sun J, Corradini S, Azab F, Shokeen M, Muz B, Miari KE, Maksimos M, Diedrich C, Asare O, Alhallak K, et al. IL-10R Inhibition reprograms tumor-associated macrophages and reverses drug resistance in multiple myeloma. Leukemia. 2024;38:2355\u201365.","journal-title":"Leukemia"},{"key":"7799_CR7","doi-asserted-by":"crossref","unstructured":"Sun J, Park C, Guenthner N, Gurley S, Zhang L, Lubben B, Adebayo O, Bash H, Chen Y, Maksimos M et al. Tumor-associated macrophages in multiple myeloma: advances in biology and therapy. J Immunother Cancer. 2022;10.","DOI":"10.1136\/jitc-2021-003975"},{"key":"7799_CR8","doi-asserted-by":"crossref","unstructured":"Uckun FM. Overcoming the immunosuppressive tumor microenvironment in multiple myeloma. Cancers (Basel). 2021;13.","DOI":"10.3390\/cancers13092018"},{"key":"7799_CR9","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1038\/s41419-019-2012-4","volume":"10","author":"R Xu","year":"2019","unstructured":"Xu R, Li Y, Yan H, Zhang E, Huang X, Chen Q, Chen J, Qu J, Liu Y, He J, et al. CCL2 promotes macrophages-associated chemoresistance via MCPIP1 dual catalytic activities in multiple myeloma. Cell Death Dis. 2019;10:781.","journal-title":"Cell Death Dis"},{"key":"7799_CR10","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nrc.2017.20","volume":"17","author":"GM Sizemore","year":"2017","unstructured":"Sizemore GM, Pitarresi JR, Balakrishnan S, Ostrowski MC. The ETS family of oncogenic transcription factors in solid tumours. Nat Rev Cancer. 2017;17:337\u201351.","journal-title":"Nat Rev Cancer"},{"key":"7799_CR11","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1002\/med.21575","volume":"40","author":"M Hsing","year":"2020","unstructured":"Hsing M, Wang Y, Rennie PS, Cox ME, Cherkasov A. ETS transcription factors as emerging drug targets in cancer. Med Res Rev. 2020;40:413\u201330.","journal-title":"Med Res Rev"},{"key":"7799_CR12","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1158\/0008-5472.CAN-09-3092","volume":"70","author":"J Jane-Valbuena","year":"2010","unstructured":"Jane-Valbuena J, Widlund HR, Perner S, Johnson LA, Dibner AC, Lin WM, Baker AC, Nazarian RM, Vijayendran KG, Sellers WR, et al. An oncogenic role for ETV1 in melanoma. Cancer Res. 2010;70:2075\u201384.","journal-title":"Cancer Res"},{"key":"7799_CR13","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1053\/j.gastro.2016.06.005","volume":"151","author":"S Heeg","year":"2016","unstructured":"Heeg S, Das KK, Reichert M, Bakir B, Takano S, Caspers J, Aiello NM, Wu K, Neesse A, Maitra A, et al. ETS-Transcription factor ETV1 regulates stromal expansion and metastasis in pancreatic cancer. Gastroenterology. 2016;151:540\u2013e553514.","journal-title":"Gastroenterology"},{"key":"7799_CR14","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1186\/s13046-022-02475-2","volume":"41","author":"T Zhang","year":"2022","unstructured":"Zhang T, Wang Y, Xie M, Ji X, Luo X, Chen X, Zhang B, Liu D, Feng Y, Sun M, et al. HGF-mediated elevation of ETV1 facilitates hepatocellular carcinoma metastasis through upregulating PTK2 and c-MET. J Exp Clin Cancer Res. 2022;41:275.","journal-title":"J Exp Clin Cancer Res"},{"key":"7799_CR15","doi-asserted-by":"publisher","first-page":"939806","DOI":"10.3389\/fimmu.2022.939806","volume":"13","author":"X Shen","year":"2022","unstructured":"Shen X, Zhou C, Feng H, Li J, Xia T, Cheng X, Zhao R, Zou D. ETV1 positively correlated with immune infiltration and poor clinical prognosis in colorectal cancer. Front Immunol. 2022;13:939806.","journal-title":"Front Immunol"},{"key":"7799_CR16","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s00262-024-03914-z","volume":"74","author":"T Han","year":"2025","unstructured":"Han T, Guo X, Xie J, Tong W, Zhang L. SUMO modified ETV1 promotes M2-polarized tumor-associated macrophage infiltration and cancer progression by facilitating CCL2 transcription in esophageal squamous cell carcinoma cells. Cancer Immunol Immunother. 2025;74:87.","journal-title":"Cancer Immunol Immunother"},{"key":"7799_CR17","doi-asserted-by":"publisher","first-page":"7239","DOI":"10.1093\/nar\/gkab378","volume":"49","author":"S Oerum","year":"2021","unstructured":"Oerum S, Meynier V, Catala M, Tisne C. A comprehensive review of m6A\/m6Am RNA methyltransferase structures. Nucleic Acids Res. 2021;49:7239\u201355.","journal-title":"Nucleic Acids Res"},{"key":"7799_CR18","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1186\/s12943-024-02089-6","volume":"23","author":"D Chen","year":"2024","unstructured":"Chen D, Gu X, Nurzat Y, Xu L, Li X, Wu L, Jiao H, Gao P, Zhu X, Yan D, et al. Writers, readers, and erasers RNA modifications and drug resistance in cancer. Mol Cancer. 2024;23:178.","journal-title":"Mol Cancer"},{"key":"7799_CR19","doi-asserted-by":"crossref","unstructured":"Tong Y, Chen Z, Wu J, Huang Q, He Y, Shang H, Xia D, Peng E, Wang Z, Liang X, Tang K. METTL3 promotes an immunosuppressive microenvironment in bladder cancer via m6A-dependent CXCL5\/CCL5 regulation. J Immunother Cancer. 2025;13.","DOI":"10.1136\/jitc-2024-011108"},{"key":"7799_CR20","doi-asserted-by":"publisher","first-page":"7640","DOI":"10.7150\/thno.61178","volume":"11","author":"Y Chen","year":"2021","unstructured":"Chen Y, Pan C, Wang X, Xu D, Ma Y, Hu J, Chen P, Xiang Z, Rao Q, Han X. Silencing of METTL3 effectively hinders invasion and metastasis of prostate cancer cells. Theranostics. 2021;11:7640\u201357.","journal-title":"Theranostics"},{"key":"7799_CR21","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41419-024-07317-x","volume":"16","author":"C Zhang","year":"2025","unstructured":"Zhang C, Yang T, Chen H, Ding X, Chen H, Liang Z, Zhao Y, Ma S, Liu X. METTL3 Inhibition promotes radiosensitivity in hepatocellular carcinoma through regulation of SLC7A11 expression. Cell Death Dis. 2025;16:9.","journal-title":"Cell Death Dis"},{"key":"7799_CR22","doi-asserted-by":"publisher","first-page":"142880","DOI":"10.1016\/j.ijbiomac.2025.142880","volume":"309","author":"ZM Zhu","year":"2025","unstructured":"Zhu ZM, Huo FC, Shi C, Li MT, Zhou Y, Zhang LS, Pei DS. METTL3-mediated m6A modification of PAK6 drives cervical cancer progression through activating MAPK14. Int J Biol Macromol. 2025;309:142880.","journal-title":"Int J Biol Macromol"},{"key":"7799_CR23","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.1007\/s10565-021-09690-1","volume":"39","author":"F Che","year":"2023","unstructured":"Che F, Ye X, Wang Y, Wang X, Ma S, Tan Y, Mao Y, Luo Z. METTL3 facilitates multiple myeloma tumorigenesis by enhancing YY1 stability and pri-microRNA-27 maturation in m(6)A-dependent manner. Cell Biol Toxicol. 2023;39:2033\u201350.","journal-title":"Cell Biol Toxicol"},{"key":"7799_CR24","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1007\/s00277-023-05283-6","volume":"102","author":"X Huang","year":"2023","unstructured":"Huang X, Yang Z, Li Y, Long X. m6A methyltransferase METTL3 facilitates multiple myeloma cell growth through the m6A modification of BZW2. Ann Hematol. 2023;102:1801\u201310.","journal-title":"Ann Hematol"},{"key":"7799_CR25","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/s41419-022-04747-3","volume":"13","author":"M Liu","year":"2022","unstructured":"Liu M, Li H, Zhang H, Zhou H, Jiao T, Feng M, Na F, Sun M, Zhao M, Xue L, Xu L. RBMS1 promotes gastric cancer metastasis through autocrine IL-6\/JAK2\/STAT3 signaling. Cell Death Dis. 2022;13:287.","journal-title":"Cell Death Dis"},{"key":"7799_CR26","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1038\/s41418-022-01012-0","volume":"29","author":"J Zhang","year":"2022","unstructured":"Zhang J, Zhang G, Zhang W, Bai L, Wang L, Li T, Yan L, Xu Y, Chen D, Gao W, et al. Loss of RBMS1 promotes anti-tumor immunity through enabling PD-L1 checkpoint Blockade in triple-negative breast cancer. Cell Death Differ. 2022;29:2247\u201361.","journal-title":"Cell Death Differ"},{"key":"7799_CR27","doi-asserted-by":"publisher","first-page":"e2307122","DOI":"10.1002\/advs.202307122","volume":"11","author":"Y Sun","year":"2024","unstructured":"Sun Y, Chen D, Sun S, Ren M, Zhou L, Chen C, Zhao J, Wei H, Zhao Q, Qi Y, et al. RBMS1 coordinates with the m(6)A reader YTHDF1 to promote NSCLC metastasis through stimulating S100P translation. Adv Sci (Weinh). 2024;11:e2307122.","journal-title":"Adv Sci (Weinh)"},{"key":"7799_CR28","doi-asserted-by":"publisher","first-page":"2534","DOI":"10.1002\/jcb.25967","volume":"118","author":"W Wei","year":"2017","unstructured":"Wei W, Ji X, Guo X, Ji S. Regulatory role of N(6) -methyladenosine (m(6) A) methylation in RNA processing and human diseases. J Cell Biochem. 2017;118:2534\u201343.","journal-title":"J Cell Biochem"},{"key":"7799_CR29","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.tig.2019.12.007","volume":"36","author":"Y Lee","year":"2020","unstructured":"Lee Y, Choe J, Park OH, Kim YK. Molecular mechanisms driving mRNA degradation by m(6)A modification. Trends Genet. 2020;36:177\u201388.","journal-title":"Trends Genet"},{"key":"7799_CR30","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1080\/15384101.2023.2170521","volume":"22","author":"CJ Chen","year":"2023","unstructured":"Chen CJ, Huang JY, Huang JQ, Deng JY, Shangguan XH, Chen AZ, Chen LT, Wu WH. Metformin attenuates multiple myeloma cell proliferation and encourages apoptosis by suppressing METTL3-mediated m6A methylation of THRAP3, RBM25, and USP4. Cell Cycle. 2023;22:986\u20131004.","journal-title":"Cell Cycle"},{"key":"7799_CR31","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.canlet.2022.01.008","volume":"530","author":"K Xu","year":"2022","unstructured":"Xu K, Zhang Q, Chen M, Li B, Wang N, Li C, Gao Z, Zhang D, Yang L, Xu Z, et al. N(6)-methyladenosine modification regulates Imatinib resistance of Gastrointestinal stromal tumor by enhancing the expression of multidrug transporter MRP1. Cancer Lett. 2022;530:85\u201399.","journal-title":"Cancer Lett"},{"key":"7799_CR32","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.3892\/ijo.2020.5133","volume":"57","author":"S Oh","year":"2020","unstructured":"Oh S, Song H, Freeman WM, Shin S, Janknecht R. Cooperation between ETS transcription factor ETV1 and histone demethylase JMJD1A in colorectal cancer. Int J Oncol. 2020;57:1319\u201332.","journal-title":"Int J Oncol"},{"key":"7799_CR33","doi-asserted-by":"publisher","first-page":"188","DOI":"10.3389\/fonc.2020.00188","volume":"10","author":"J Zhou","year":"2020","unstructured":"Zhou J, Tang Z, Gao S, Li C, Feng Y, Zhou X. Tumor-Associated macrophages: recent insights and therapies. Front Oncol. 2020;10:188.","journal-title":"Front Oncol"},{"key":"7799_CR34","doi-asserted-by":"crossref","unstructured":"Cencini E, Fabbri A, Sicuranza A, Gozzetti A, Bocchia M. The role of tumor-associated macrophages in hematologic malignancies. Cancers (Basel). 2021;13.","DOI":"10.3390\/cancers13143597"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-07799-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-07799-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-07799-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T14:50:37Z","timestamp":1774018237000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-07799-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,13]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["7799"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-07799-7","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,13]]},"assertion":[{"value":"25 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal procedures were approved by the Ethics Committee of the Harbin Medical University and were conducted in accordance with the Guide for the Care and Use of Laboratory Animals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no potential conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"394"}}